TLPHTalphera, Inc.

$18M

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$941,000+15.0% YoY

Gross Profit

-$2M-215.9% margin

Operating Income

-$13M-1419.9% margin

Net Income

-$12M-1319.0% margin

EPS (Diluted)

$-3.15

QoQ Revenue Growth

+255.1%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$115M

Total Liabilities

$134M

Stockholders' Equity

-$18M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$941,000	$818,000	+15.0%
Gross Profit	-$2M	-$3M	+36.7%
Operating Income	-$13M	-$7M	-86.8%
Net Income	-$12M	-$11M	-17.7%

TLPH Q2 2019 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena